PFAS Continuing Education for Clinicians
Per- and polyfluoroakyl substances, or PFAS, are a growing topic of interest in the United States. Recently, the US Environmental Protection Agency (EPA) released a new lifetime health advisory level for PFAS in water. This led to discovery of widespread contamination of water systems which exceeded this new value. PFAS are classified as emerging contaminants which are characterized by “a perceived, potential, or real threat to human health or the environment or by a lack of published health standards”. These chemicals are ubiquitous in a variety of environments, and >95% of people in the US have measurable amounts of PFAS present in their body. With this widespread exposure, it is necessary that clinicians are well-informed to handle concerns of communities where contamination has occurred. This presentation is designed to assist clinicians by offering peer-reviewed, up-to-date literature about PFAS, the known and potential health effects associated with PFAS exposure, and information on how to address potential patient concerns following exposure to PFAS. This presentation is available for Physicians, Nurses, Other Health Professionals, and Certified Public Health Professionals continuing education.
- If you would like to go directly to training follow this link
- If you would like to receive continuing education credits for this training go to this link
Continuing Education Information:
At the conclusion of the session, the participant will be able to:
- Describe characteristics of PFAS.
- Identify uses of PFAS
- Explain the relationship of cancer to PFAS
- Identify routes of exposure for PFAS
- Describe Reproductive effects of PFAS
- Identify pregnancy outcomes associated with PFAS exposure.
- Explain how to address a patient’s concerns about breastfeeding after exposure to PFAS.
- Describe when blood testing is appropriate after potential exposure to PFAS
Origination date December 15, 2016
Expiration date: December 15, 2018
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0 CDC provider number 98614.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.
Disclosure: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products,suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Planning committee reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
Fees: No fees are charged for CDC’s CE activities.
- Page last reviewed: March 22, 2018
- Page last updated: March 22, 2018
- Content source: